Department of Thoracic Surgery, Nanjing Chest Hospital, Treatment and Research Center for Pulmonary Nodule in Nanjing Medical University, Nanjing, China.
Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Thorac Cardiovasc Surg. 2021 Mar;69(2):173-180. doi: 10.1055/s-0040-1713878. Epub 2020 Sep 4.
The aim of this study was to compare early outcome between intercostal uniportal video-assisted thoracoscopic surgery (IU-VATS) versus subxiphoid uniportal video-assisted thoracoscopic surgery (SU-VATS) in thymectomy for non-myasthenic early-stage thymoma.
Retrospective analysis of 76 cases completed in our hospital from May 2018 to September 2019 with subxiphoid uniportal thoracoscopic thymectomy; a single incision of ∼3 cm was made ∼1 cm under the xiphoid process. The control group included 213 patients who received intercostal uniportal thoracoscopic thymectomy from August 2015, and propensity score matching was conducted. All patients who were clinically diagnosed with thymic tumor before surgery were treated with thymectomy. Perioperative outcomes between SU-VATS ( = 76) and IU-VATS, = 76 were compared.
After propensity score matching, there were no statistically significant differences between the two groups in terms of age, gender, disease stage, maximal tumor size, or other baseline demographic and clinical variables. All operation was successfully completed; there were no significant differences in the operative time (88 vs. 81 minutes, = 0.63), intraoperative blood loss (55 vs. 46 mL, = 0.47), postoperative drainage time (2.2 vs. 2.5 days, = 0.72), and postoperative hospital stay (3.2 vs. 3.4 days, = 0.78) between the two groups. The visual analog scale (VAS) on postoperative days 1, 3, 7, and 30 was less in the SU-VATS group than that in the IU-VATS group. The VAS on days 60 and 180 did not differ significantly between the two groups.
Thymectomy using SU-VATS is a feasible procedure; it might reduce early postoperative pain and lead to faster recovery.
本研究旨在比较肋间单孔电视胸腔镜手术(IU-VATS)与剑突下单孔电视胸腔镜手术(SU-VATS)治疗非重症早期胸腺瘤的早期结果。
回顾性分析 2018 年 5 月至 2019 年 9 月在我院行剑突下单孔胸腔镜胸腺切除术的 76 例患者的资料;剑突下约 1cm 处作一约 3cm 的单切口。对照组为 2015 年 8 月以来接受肋间单孔电视胸腔镜胸腺切除术的 213 例患者,采用倾向评分匹配。所有术前临床诊断为胸腺肿瘤的患者均行胸腺切除术。比较 SU-VATS(n=76)和 IU-VATS(n=76)两组患者的围手术期结果。
经倾向评分匹配后,两组患者在年龄、性别、疾病分期、最大肿瘤直径及其他基线人口统计学和临床变量方面无统计学差异。所有手术均顺利完成;手术时间(88 与 81 分钟,=0.63)、术中出血量(55 与 46ml,=0.47)、术后引流时间(2.2 与 2.5 天,=0.72)和术后住院时间(3.2 与 3.4 天,=0.78)差异均无统计学意义。SU-VATS 组术后第 1、3、7、30 天的视觉模拟评分(VAS)均低于 IU-VATS 组,两组术后 60 天和 180 天的 VAS 差异均无统计学意义。
SU-VATS 行胸腺切除术是一种可行的方法,可能减轻术后早期疼痛,促进更快康复。